151 related articles for article (PubMed ID: 33866226)
1. Efficacy of recombinant human soluble thrombomodulin in induction therapy for acute promyelocytic leukemia.
Matsuda K; Jo T; Toyama K; Nakazaki K; Matsui H; Fushimi K; Yasunaga H
Thromb Res; 2021 Jun; 202():173-175. PubMed ID: 33866226
[No Abstract] [Full Text] [Related]
2. Thrombomodulin alfa treatment in patients with acute promyelocytic leukemia and disseminated intravascular coagulation: a retrospective analysis of an open-label, multicenter, post-marketing surveillance study cohort.
Matsushita T; Watanabe J; Honda G; Mimuro J; Takahashi H; Tsuji H; Eguchi Y; Kitajima I; Sakata Y
Thromb Res; 2014 May; 133(5):772-81. PubMed ID: 24636871
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human soluble thrombomodulin safely and effectively rescues acute promyelocytic leukemia patients from disseminated intravascular coagulation.
Ikezoe T; Takeuchi A; Isaka M; Arakawa Y; Iwabu N; Kin T; Anabuki K; Sakai M; Taniguchi A; Togitani K; Yokoyama A
Leuk Res; 2012 Nov; 36(11):1398-402. PubMed ID: 22917769
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of disseminated intravascular coagulation in patients with acute promyelocytic leukemia, and its treatment using recombinant human soluble thrombomodulin.
Ikezoe T
Int J Hematol; 2014 Jul; 100(1):27-37. PubMed ID: 24217998
[TBL] [Abstract][Full Text] [Related]
5. The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia.
Barbui T; Finazzi G; Falanga A
Blood; 1998 May; 91(9):3093-102. PubMed ID: 9558362
[No Abstract] [Full Text] [Related]
6. DIC Complicating APL Successfully Treated With Recombinant Thrombomodulin Alfa.
Saito A; Okamoto Y; Seki Y; Matsunaga M; Nakagawa S; Kodama Y; Nishikawa T; Tanabe T; Kawano Y
J Pediatr Hematol Oncol; 2016 Aug; 38(6):e189-90. PubMed ID: 27123666
[TBL] [Abstract][Full Text] [Related]
7. Thrombomodulin enhances the antifibrinolytic and antileukemic effects of all-trans retinoic acid in acute promyelocytic leukemia cells.
Ikezoe T; Yang J; Nishioka C; Isaka M; Iwabu N; Sakai M; Taniguchi A; Honda G; Yokoyama A
Exp Hematol; 2012 Jun; 40(6):457-65. PubMed ID: 22327096
[TBL] [Abstract][Full Text] [Related]
8. In vitro studies on the role of recombinant human soluble thrombomodulin in the context of retinoic acid mediated APL differentiation syndrome.
Kojima S; Nishioka C; Chi S; Yokoyama A; Ikezoe T
Leuk Res; 2017 Dec; 63():1-9. PubMed ID: 29055789
[TBL] [Abstract][Full Text] [Related]
9. The impact of oral arsenic and all-trans-retinoic acid on coagulopathy in acute promyelocytic leukemia.
Zhu HH; Guo ZP; Jia JS; Jiang Q; Jiang H; Huang XJ
Leuk Res; 2018 Feb; 65():14-19. PubMed ID: 29232592
[TBL] [Abstract][Full Text] [Related]
10. All-trans retinoic acid for the treatment of acute promyelocytic leukemia in pregnancy.
Incerpi MH; Miller DA; Posen R; Byrne JD
Obstet Gynecol; 1997 May; 89(5 Pt 2):826-8. PubMed ID: 9166337
[TBL] [Abstract][Full Text] [Related]
11. What's new in the pathogenesis of the coagulopathy in acute promyelocytic leukemia?
Mantha S; Tallman MS; Soff GA
Curr Opin Hematol; 2016 Mar; 23(2):121-6. PubMed ID: 26760586
[TBL] [Abstract][Full Text] [Related]
12. A case of ischemic stroke in acute promyelocytic leukemia at initial presentation. Relevance of all-trans retinoic acid treatment.
Carella AM; Antonucci G; Conte M; Di Pumpo M; Antonucci E; Ponziano E
Cardiovasc Hematol Disord Drug Targets; 2010 Mar; 10(1):1-6. PubMed ID: 20041837
[TBL] [Abstract][Full Text] [Related]
13. All trans retinoic acid treatment for patients with acute promyelocytic leukemia.
Fenaux P; Castaigne S; Chomienne C; Dombret H; Degos L
Leukemia; 1992; 6 Suppl 1():64-6. PubMed ID: 1548938
[No Abstract] [Full Text] [Related]
14. Clinical features and treatment outcomes of six patients with disseminated intravascular coagulation resulting from acute promyelocytic leukemia and treated with recombinant human soluble thrombomodulin at a single institution.
Kawano N; Kuriyama T; Yoshida S; Yamashita K; Ochiai H; Nakazaki S; Tasaki A; Ueda A
Intern Med; 2013; 52(1):55-62. PubMed ID: 23291674
[TBL] [Abstract][Full Text] [Related]
15. [Acute promyelocytic leukemia with asymptomatic cerebral hemorrhage].
Koi S; Nogami A; Fujiwara H; Bando K; Saito M; Osada Y; Tanaka K; Sakashita C; Yoshifuji K; Okada K; Umezawa Y; Nagao T; Yamamoto M; Mori T
Rinsho Ketsueki; 2023; 64(11):1426-1430. PubMed ID: 38072429
[TBL] [Abstract][Full Text] [Related]
16. Acute promyelocytic leukemia in pregnancy: all-trans retinoic acid as a newer therapeutic option.
Celo JS; Kim HC; Houlihan C; Canavan BF; Manzullo GP; Saidi P
Obstet Gynecol; 1994 May; 83(5 Pt 2):808-11. PubMed ID: 8159357
[TBL] [Abstract][Full Text] [Related]
17. Combined therapy with all-trans-retinoic acid and high-dose chemotherapy in patients with hyperleukocytic acute promyelocytic leukemia and severe visceral hemorrhage.
Dombret H; Sutton L; Duarte M; Daniel MT; Leblond V; Castaigne S; Degos L
Leukemia; 1992 Dec; 6(12):1237-42. PubMed ID: 1453767
[TBL] [Abstract][Full Text] [Related]
18. Low molecular weight heparin in the prophylaxis and treatment of disseminated intravascular coagulation in acute promyelocytic leukemia.
Gillis S; Dann EJ; Eldor A
Eur J Haematol; 1995 Jan; 54(1):59-60. PubMed ID: 7859878
[No Abstract] [Full Text] [Related]
19. [Thrombosis and DIC in hematological malignancies].
Asakura H
Rinsho Ketsueki; 2014 Oct; 55(10):2066-75. PubMed ID: 25297773
[No Abstract] [Full Text] [Related]
20. Advances in the management of coagulopathy in acute promyelocytic leukemia.
Sanz MA; Montesinos P
Thromb Res; 2020 Jul; 191 Suppl 1():S63-S67. PubMed ID: 32736781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
